Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event

NCT07499128 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

136

Enrollment

NIH

Sponsor class

Conditions

Cytokine Release Syndrome
Neoplasms
Lymphoma
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Multiple Myeloma
Lymphoma Mantle-cell
Immunotherapy
Cell and Tissue-Based Therapy
Cytokines
Monitoring Physiologic
Immune Monitoring
Wearable Electronic Devices
Thermometry
Body Temperature
Antibodies Bispecific
Receptors Chimeric Antigen

Interventions

DEVICE: TempTraq
DEVICE: VitalTraq

Sponsor

National Cancer Institute (NCI)